Provided by Tiger Trade Technology Pte. Ltd.

Nice Ltd

110.11
-0.1500-0.14%
Post-market: 110.110.00000.00%16:10 EDT
Volume:296.96K
Turnover:32.80M
Market Cap:6.54B
PE:11.39
High:111.78
Open:111.78
Low:109.23
Close:110.26
52wk High:180.61
52wk Low:94.65
Shares:59.40M
Float Shares:59.40M
Volume Ratio:0.44
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.67
EPS(LYR):9.67
ROE:16.37%
ROA:7.87%
PB:1.69
PE(LYR):11.39

Loading ...

Stock Track | Nice Ltd Soars 11.64% Intraday on Strong Q4 Earnings, AI Growth and $600M Share Buyback

Stock Track
·
Feb 19

NICE Posts Double-Digit Cloud and AI Growth for 2025, Adds $600 Million Buyback and New Credit Line

TIPRANKS
·
Feb 19

NICE Q4 cloud revenue rises on strong demand for AI-native platform, sets share repurchase program

Reuters
·
Feb 19

Stock Track | Nice Ltd Soars 5.55% in Pre-market on Strong Q4 Earnings Beat

Stock Track
·
Feb 19

Nice reports Q4 EPS $3.24, consensus $3.21

TIPRANKS
·
Feb 19

GUIDANCE: (NICE) NiCE Expects 2026 Adjusted EPS Range $10.85 to $11.05, vs. FactSet Est of $11.21

MT Newswires Live
·
Feb 19

NICE Q4 Adj. EPS $3.24 Beats $3.23 Estimate, Sales $786.496M Beat $782.285M Estimate

Benzinga
·
Feb 19

Earning Preview: Nice Ltd Q4 revenue is expected to increase by 9.05%, and institutional views are constructive

Earnings Agent
·
Feb 12

Press Release: NiCE Provides Webcast and Dial-in Details for its Fourth Quarter 2025 Results Teleconference

Dow Jones
·
Feb 05

8 Software Stocks to Buy That Are Actually Profitable -- and Cheap -- Barrons.com

Dow Jones
·
Feb 04

These software stocks could rise as much as 75%. But is now the time to buy?

Dow Jones
·
Feb 03

NiCE Launches AI Performance Lab for Enterprise-Scale Agent Evaluations

MT Newswires Live
·
Jan 20

NICE Is Maintained at Buy by Rosenblatt

Dow Jones
·
Dec 23, 2025

Intel, Adobe and these other 'AI loser' stocks could get left behind in the next phase of the tech boom

Dow Jones
·
Dec 08, 2025

NICE Cut to Neutral From Outperform by Wedbush

Dow Jones
·
Dec 08, 2025

Nice Ltd : Wedbush Cuts to Neutral From Outperform; Cuts Target Price to $120 From $170

THOMSON REUTERS
·
Dec 08, 2025

Wedbush Downgrades NICE to Neutral From Outperform, Cuts Price Target to $120 From $170

MT Newswires Live
·
Dec 08, 2025

Britain is missing out on pharma investment thanks to medicine rationing

cityam
·
Dec 03, 2025

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?

Benzinga_recent_news
·
Nov 26, 2025

Autolus Therapeutics announces NICE draft guidance recommending Aucatzyl

TIPRANKS
·
Nov 25, 2025